Blood test may spot pregnancy danger early
NCT ID NCT01490489
First seen Nov 18, 2025 · Last updated May 01, 2026 · Updated 20 times
Summary
This study looked at whether a protein called EG-VEGF in the blood of pregnant women could help predict serious conditions like pre-eclampsia (high blood pressure) and poor fetal growth. Researchers measured EG-VEGF levels in 142 women around 14-18 weeks of pregnancy. The goal was to see if this protein could serve as an early warning sign, allowing doctors to monitor and manage these risks sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical investigation center of the Grenoble University Hospital
Grenoble, Isere, 38043, France
Conditions
Explore the condition pages connected to this study.